Patents by Inventor Marit M. VAN BUUREN

Marit M. VAN BUUREN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T CELL MANUFACTURING COMPOSITIONS AND METHODS
    Publication number: 20220280621
    Abstract: The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.
    Type: Application
    Filed: May 7, 2020
    Publication date: September 8, 2022
    Inventors: Marit M. van Buuren, Divya Reddy Lenkala, Jessica Kohler, Flavian Duvalle Brown, Christina Murphy Kuksin, Joost Huibert van den Berg, Renate de Boer, Noor Bakker, Ton Schumacher
  • T CELL MANUFACTURING COMPOSTIONS AND METHODS
    Publication number: 20220177840
    Abstract: The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.
    Type: Application
    Filed: October 5, 2021
    Publication date: June 9, 2022
    Inventors: Marit M. VAN BUUREN, Divya Reddy LENKALA, Joost Huibert VAN DEN BURG, Jessica Kohler, Matthew GOLDSTEIN, Ed Fritsch, Renate DE BOER, Ton SCHUMACHER, Noor BAKKER
  • T cell manufacturing compositions and methods
    Patent number: 11162072
    Abstract: The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: November 2, 2021
    Assignees: BIONTECH US INC., Stichting Het Nederlands Kanker Instituut—Antoni Van Leeuwenhoek Ziekenhuis
    Inventors: Marit M. Van Buuren, Divya Reddy Lenkala, Joost Huibert Van Den Berg, Jessica Kohler, Matthew Goldstein, Ed Fritsch, Renate De Boer, Ton Schumacher, Noor Bakker
  • T CELL MANUFACTURING COMPOSITIONS AND METHODS
    Publication number: 20200165567
    Abstract: The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.
    Type: Application
    Filed: January 6, 2020
    Publication date: May 28, 2020
    Inventors: Marit M. VAN BUUREN, Divya Reddy LENKALA, Joost Huibert VAN DEN BERG, Jessica KOHLER, Matthew GOLDSTEIN, Ed FRITSCH, Renate DE BOER, Ton SCHUMACHER, Noor Bakker